menu
    • menu

    Company profile for Kashiv BioSciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products. Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead can...
    Since its establishment in 2011, Kashiv BioSciences has evolved into a premier, fully integrated biopharmaceutical company offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products. Kashiv is built on patient-focused innovation and leverages its expertise in small and large molecules to develop a clinically differentiated pipeline of novel compounds and biosimilars with lead candidates in various therapeutic areas, including CNS, endocrinology, cancer, and several debilitating orphan diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kashiv BioSciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    995 US HWY 202/206 Bridgewater, NJ 08807
    Telephone
    Telephone
    908.895.1520
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kashivbiosciences.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/kashiv-pharma
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kashiv Submits BLA To FDA, EMA Accepts ADL-018 Xolair Biosimilar
    Kashiv Submits BLA To FDA, EMA Accepts ADL-018 Xolair Biosimilar

    06 Oct 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-10-06/kashiv-biosciences-announces-submission-of-biologics-license-application-to-us-fda-and-acceptance

    PHARMAWEB
    06 Oct 2025
    Share Share
    Kashiv Biosciences & JAMP Pharma Launch Pexegra & Filra in Canada
    Kashiv Biosciences & JAMP Pharma Launch Pexegra & Filra in Canada

    24 Sep 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-09-24/kashiv-biosciences-and-jamp-pharma-corporation-announce-the-launch-of-pexegra-and-filra-biosimilar

    PHARMIWEB
    24 Sep 2025
    Share Share
    Kashiv Bio, CRISTÁLIA License Omalizumab Biosimilar ADL-018
    Kashiv Bio, CRISTÁLIA License Omalizumab Biosimilar ADL-018

    11 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-11/kashiv-biosciences-and-cristália-enter-into-licensing-and-supply-agreement-for-omalizumab-biosimilar

    PHARMAWEB
    11 Sep 2025
    Share Share
    Kashiv & MS Pharma Ink MENA License for XOLAIR Biosimilar ADL-018
    Kashiv & MS Pharma Ink MENA License for XOLAIR Biosimilar ADL-018

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805355377/en/Kashiv-BioSciences-and-MS-Pharma-Enter-into-MENA-License-and-Supply-Agreement-for-ADL-018-Biosimilar-Candidate-to-XOLAIR-bOmalizumab

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Kashiv BioSciences Reports Positive Results for ADL-018 Study
    Kashiv BioSciences Reports Positive Results for ADL-018 Study

    25 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250625166139/en/Kashiv-BioSciences-Announces-Positive-Topline-Results-from-Confirmatory-Efficacy-Study-of-ADL-018-Biosimilar-Candidate-to-XOLAIR-omalizumab

    BUSINESSWIRE
    25 Jun 2025
    Share Share
    Positive Results from Efficacy Study for Biosimilar to Xolair®
    Positive Results from Efficacy Study for Biosimilar to Xolair®

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3104830/0/en/Positive-Top-Line-Results-from-Confirmatory-Efficacy-Study-for-Proposed-Biosimilar-to-Xolair-omalizumab.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search